{"id":879853,"date":"2025-08-28T01:06:01","date_gmt":"2025-08-28T05:06:01","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-present-at-upcoming-investor-conferences-2\/"},"modified":"2025-08-28T01:06:01","modified_gmt":"2025-08-28T05:06:01","slug":"argenx-to-present-at-upcoming-investor-conferences-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-present-at-upcoming-investor-conferences-2\/","title":{"rendered":"argenx to Present at Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">\n        <strong>August 28, 2025<\/strong><\/p>\n<p>        <strong>Amsterdam, the Netherlands<\/strong> \u2013 argenx (Euronext &amp; Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that members of the management team will participate in the following investor conferences in September:<\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">\n          <strong>2025 Wells Fargo Healthcare Conference<\/strong>. Fireside chat on Thursday, September 4, 2025 at 8:00 a.m. ET in Boston, MA.<\/li>\n<li style=\"text-align:justify\">\n          <strong>Morgan Stanley 23rd Annual Global Healthcare Conference<\/strong>. Fireside chat on Monday, September 8, 2025 at 7:00 a.m. ET in New York, NY.<\/li>\n<\/ul>\n<p align=\"justify\">A live webcast of the presentations may be accessed on the Investors section of the argenx website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ltjIbeOnRmZ7t-vUAh1sQZkjd4Yixluyy8yioFKKGlsEFacH05Fe3avRdJKYVCKLGwJeELvxyM46pJLCOC0LR9O26hhHCzTA7t_sAJWCLLItLPidA0Nqqr20m1hUQfGR\" rel=\"nofollow\" target=\"_blank\">argenx.com\/investors<\/a>. A replay of the webcasts will be available on the argenx website for approximately 30 days following the presentation.<\/p>\n<p align=\"justify\">\n        <strong>About argenx<\/strong>\n      <\/p>\n<p align=\"justify\">argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx developed and is commercializing the first approved neonatal Fc receptor (FcRn) blocker and is evaluating its broad potential in multiple serious autoimmune diseases while advancing several earlier stage experimental medicines within its therapeutic franchises. For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=06M7xnAeMbtLJfF2uBT0lPhEo8Nt05rt-SyS_s9QZaI-SK8EH5hFMaFGPAbeEJcm18GW5Lua6TALYXWhmZxjFoA0Bm1is2z7C0-WRZPUTLg=\" rel=\"nofollow\" target=\"_blank\">www.argenx.com<\/a>\u00a0and follow us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MQkPt9-1VhHm_WzXu88ftrFWYsc9gEM73vzFcH3D8KUhMUpiZzvwWQo0UnrDQiHaKysHlVIJ621a2i5ErkcWhLLy8ZafcvKDm1BTroidHH06jbKxlggwUjFV_C8HgS1SVDouOX4LpIX3Zd9EfEVgUN9K5fihx4fr6TqQkEaFNpFipC1U-6QrIvp6E44OUwTHTGMIkwszMPXRP3qZwp73r4kMBNtVlP2--_jbaP04jaT_Xyfc7uGVygMd7eenpAPF-02PGGwwtnGC7JFBe7l9Kp77A_sYmbFEXfua-f_ZrwMvl_vXEok2SG1sTV-B_OHEZ4xxhmaecl5UEP3S5Gxo0VPp59hVOH-YC9GL6afWaLBPsXHhNA8f9oVMFy_Oq4g9L_7UqfdkJkkmlftKEZDrvXawGqcl1HaGe4XF1GOElmDBzhHKIJYhGBBXG4VcCpSJoqQZTNd9wfFbnZ8rRSdsczTc1a0umyWWRL2BNP_zBcTLc8vooHoZv2sewYAAkTLEEvmq_R0IdiwSlgG7tEs2n9lh3feeck7aW8gx13fDOLd0HVxWASd2iy1mdEd_99Zu5_4fekMxeEJZEW3iqAnjIw==\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QhMS5Xy0fFDPynMn4k3_QhqsQ698krr9hqHM3TajyPyJoHXYo-0iFu3cKr6EC1C06WKXVpjUVJAR-8FSPbBK3JIaEyqW313Zq7KdO76EIWmtZq8Fwi5UL0izfDrHFga-g-TBZ02MegwSNyfIapU0yPk4_gibrR4P8aYplDa8WRCu6AtP-DNr9wwcb98Wi8UajbsAaJIPULLAyXzq6KYQUxUvdzstq-ad9avojwTZGQ5X1HCOhAxJynKPRIlwQje0-Qw_9WIlRM3mIfFZpN64d2M1FhiKe78qGAF19qxpY1_ByjAO43Wovbfqcmj8RE3a1JF6Eu9bd089pKHWe_lJEfZCMRWYEgoaXvkoxK9A_83QMtglGHIDHzjnPRiq3z9j2xRAriczF6dCeUYt496GvzFOMekv6iviskfPDqho9aaKnM-x31kowaORqeF3i2lEqG7KOdJQAe7VY8HB-bzlKYDUq1_WZMtnJSfHWMijHWJzDHu9CKEMGWaF7avY3kNmd0S8fM8jzl6ZmkAxkk__9ghbqd-QNgsywLm_pvBkJ00XLo7kPpJ9fZZLGUqXkdzx3GcP4ALsNlecY_sm67mK6Q==\" rel=\"nofollow\" target=\"_blank\">Instagram<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pEz3w_ol4LxyD5VKheX7cv9cNL2JMCght6GdsdBVYncG6xTsrpwc0AkIpU4vl0RvRlhLOZjgmuvO5MXuASBa4CvON8R5Nh3gRMk-7KKW1ORLtcd7FgnonS35YNyn1-PPUMoiain1lvMv_MFcFKmgFODRjTBeFIrjCHF_tODGdlT-zw84XrVl8Chy56Stmn67AAmuyJviyrWwfIB-1A-obUHGKW6X8qvlAPdcvbyvLWfaIFPH38108wjfFqBCjgR5b1kuRvwDwlNW9CtIq1UVVmpk8CiV_PG2rmYA2baCToUXkRQX854-J6jaXTVhTlTg0Xh3H2XWNis8zIltn45t9r0YlIUvZ5GlfQUpDcqVyic78rqGOq-UTKYyiV4LcADROlu9jSj6dRoeVMLDgftCGoNJUGEWgxW6YOrbBZ2cs9a45WwuHiEQTjxuYCginT_HZBXNKkMCZUkcH9SHLrHHhOVkTUjDoYcwxutyLDYMsFtayR6g-7ywt5v4Apim8r6bF34AeEZaJ40bkIvaAhhtqpkmTYKSknfyhuSZ_caSzUCQZVAIZymxdQqjqTKdtkJrQLEMBMX-h4s8X1coYhMFfw==\" rel=\"nofollow\" target=\"_blank\">Facebook<\/a>, and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=cNf8PByeAvualDTwJTkyM4I44uh2SzB_j9GAZJ7g5HKZuyZzpZCIjVFGOfWGKaXQEJC1iHtY3tIKlt10xNc43UocEs4KsklAosvozu7-3t57E-zICd0H7RjAEZe7FN1S5bHTEDRsrOQllq1InLFpAKV0LsSiME9qjFikbL70Gh4leQ0evSpA9z-zKWczJI5Ybwx2iXhkZkzspy9ETPPaRU5CR3ZtgrOa7ko-EHZPpvjEY_CUtsiVZkTA3ZJY8Xp3qAow-8B4zGMsfkzSn7TMS-NwTy4JwBTiqod1y2v-dU-_clhzowqKR4OLRGH_1hfU612BnkdTEORTwNCf8l63I8oUf-UdEQxoFeZyelpwBUghv14vUuEKKYz7jcwGufS84nYMJ5QKYm9wd-J9BLhsaPr9f7yzoDtNaSF8v3nQKeEg5R08PRPgn1XKyOJ-8bsB0CaQl1Ssgnw5z-UH0Bt2FePZU9Ny0fv0CB7HbjIOYIlG53iCRECqvhZPRg5vIodEiekmIRKILJJYfwmb6ZL7aO0wZehvQW32eR80738CKi4zd_X3d9txDIfoWtmBhCAv4eZbGz-spKbc5M0umbbp4g==\" rel=\"nofollow\" target=\"_blank\">YouTube<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Contacts<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong>Media:<\/strong>\n      <\/p>\n<p align=\"justify\">Ben Petok<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QpPgHxZrvDsOpBSTujwi-qW5icD9E7sa7yKDDiuJyC5Rbsjrf9d7yq2bOCp2IXxSyAMZhYYdfW8WlrK40QXeubPFsiwk31jxejWpAOdF0yE=\" rel=\"nofollow\" target=\"_blank\">bpetok@argenx.com<\/a><\/p>\n<p align=\"justify\">\n        <strong>Investors:<\/strong>\n      <\/p>\n<p align=\"justify\">Alexandra Roy<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-Lzfs-W2VAgvX3NpjwQcjzPuUD2S-JvjqJ5HvsfnxLx-QyPDOsXiPe5SxT3eZyZ9zu4a8mQrO7ovSAatPn_COgHn-4JZo36sOcArnQpNfxE=\" rel=\"nofollow\" target=\"_blank\">aroy@argenx.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEyNDgzMyM0MDIyMDQwMjAjMjAwMzc3Mg==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/NGFlZmRkOGEtN2Q0YS00NWFkLWJlZjUtN2Q2YTI3OTIzMGM2LTEwMTUzNDUtMjAyNS0wOC0yOC1lbg==\/tiny\/argenx-SE.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>August 28, 2025 Amsterdam, the Netherlands \u2013 argenx (Euronext &amp; Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that members of the management team will participate in the following investor conferences in September: 2025 Wells Fargo Healthcare Conference. Fireside chat on Thursday, September 4, 2025 at 8:00 a.m. ET in Boston, MA. Morgan Stanley 23rd Annual Global Healthcare Conference. Fireside chat on Monday, September 8, 2025 at 7:00 a.m. ET in New York, NY. A live webcast of the presentations may be accessed on the Investors section of the argenx website at argenx.com\/investors. A replay of the webcasts will be available on the argenx website for approximately 30 &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-present-at-upcoming-investor-conferences-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;argenx to Present at Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-879853","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>argenx to Present at Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-present-at-upcoming-investor-conferences-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"argenx to Present at Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"August 28, 2025 Amsterdam, the Netherlands \u2013 argenx (Euronext &amp; Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that members of the management team will participate in the following investor conferences in September: 2025 Wells Fargo Healthcare Conference. Fireside chat on Thursday, September 4, 2025 at 8:00 a.m. ET in Boston, MA. Morgan Stanley 23rd Annual Global Healthcare Conference. Fireside chat on Monday, September 8, 2025 at 7:00 a.m. ET in New York, NY. A live webcast of the presentations may be accessed on the Investors section of the argenx website at argenx.com\/investors. A replay of the webcasts will be available on the argenx website for approximately 30 &hellip; Continue reading &quot;argenx to Present at Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-present-at-upcoming-investor-conferences-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-28T05:06:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEyNDgzMyM0MDIyMDQwMjAjMjAwMzc3Mg==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-present-at-upcoming-investor-conferences-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-present-at-upcoming-investor-conferences-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"argenx to Present at Upcoming Investor Conferences\",\"datePublished\":\"2025-08-28T05:06:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-present-at-upcoming-investor-conferences-2\\\/\"},\"wordCount\":233,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-present-at-upcoming-investor-conferences-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTEyNDgzMyM0MDIyMDQwMjAjMjAwMzc3Mg==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-present-at-upcoming-investor-conferences-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-present-at-upcoming-investor-conferences-2\\\/\",\"name\":\"argenx to Present at Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-present-at-upcoming-investor-conferences-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-present-at-upcoming-investor-conferences-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTEyNDgzMyM0MDIyMDQwMjAjMjAwMzc3Mg==\",\"datePublished\":\"2025-08-28T05:06:01+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-present-at-upcoming-investor-conferences-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-present-at-upcoming-investor-conferences-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-present-at-upcoming-investor-conferences-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTEyNDgzMyM0MDIyMDQwMjAjMjAwMzc3Mg==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTEyNDgzMyM0MDIyMDQwMjAjMjAwMzc3Mg==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-present-at-upcoming-investor-conferences-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"argenx to Present at Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"argenx to Present at Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-present-at-upcoming-investor-conferences-2\/","og_locale":"en_US","og_type":"article","og_title":"argenx to Present at Upcoming Investor Conferences - Market Newsdesk","og_description":"August 28, 2025 Amsterdam, the Netherlands \u2013 argenx (Euronext &amp; Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that members of the management team will participate in the following investor conferences in September: 2025 Wells Fargo Healthcare Conference. Fireside chat on Thursday, September 4, 2025 at 8:00 a.m. ET in Boston, MA. Morgan Stanley 23rd Annual Global Healthcare Conference. Fireside chat on Monday, September 8, 2025 at 7:00 a.m. ET in New York, NY. A live webcast of the presentations may be accessed on the Investors section of the argenx website at argenx.com\/investors. A replay of the webcasts will be available on the argenx website for approximately 30 &hellip; Continue reading \"argenx to Present at Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-present-at-upcoming-investor-conferences-2\/","og_site_name":"Market Newsdesk","article_published_time":"2025-08-28T05:06:01+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEyNDgzMyM0MDIyMDQwMjAjMjAwMzc3Mg==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-present-at-upcoming-investor-conferences-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-present-at-upcoming-investor-conferences-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"argenx to Present at Upcoming Investor Conferences","datePublished":"2025-08-28T05:06:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-present-at-upcoming-investor-conferences-2\/"},"wordCount":233,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-present-at-upcoming-investor-conferences-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEyNDgzMyM0MDIyMDQwMjAjMjAwMzc3Mg==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-present-at-upcoming-investor-conferences-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-present-at-upcoming-investor-conferences-2\/","name":"argenx to Present at Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-present-at-upcoming-investor-conferences-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-present-at-upcoming-investor-conferences-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEyNDgzMyM0MDIyMDQwMjAjMjAwMzc3Mg==","datePublished":"2025-08-28T05:06:01+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-present-at-upcoming-investor-conferences-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-present-at-upcoming-investor-conferences-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-present-at-upcoming-investor-conferences-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEyNDgzMyM0MDIyMDQwMjAjMjAwMzc3Mg==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEyNDgzMyM0MDIyMDQwMjAjMjAwMzc3Mg=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-present-at-upcoming-investor-conferences-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"argenx to Present at Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/879853","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=879853"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/879853\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=879853"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=879853"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=879853"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}